IP Library Patent Application 17001447
Patent Application
App. No. 17/001,447

METHOD OF TREATING DEPRESSION

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/001,447
Abstract

Methods are disclosed herein for treating depression in the subject. A method includes the use of Botulinum toxin to cause paralysis of a facial muscle, such as the depressor anguli oris, procerus, frontalis , orbicularis oculi, or corrugator supercilii muscle to treat depression in the subject.

Claims (13)

1 . A method for treating an affective disorder in a subject, comprising:

administering a therapeutically effective amount of a composition comprising a botulinum toxin to one or more facial muscle involved in frowning, scowling or a sad appearance; wherein the therapeutically effective amount is an amount sufficient to cause paralysis of the one or more facial muscle;

thereby treating the affective disorder in the subject.

2 . The method of claim 1 , wherein the one or more facial muscle involved in frowning, scowling or a sad appearance is selected from the group consisting of frontalis , orbicularis oculi, procerus, corrugator supercilii, and depressor anguli oris muscle.

3 . The method of claim 1 , wherein the one or more facial muscle is a frontalis muscle, an orbicularis oculi muscle, or a procerus muscle.

4 . The method of claim 1 , wherein the one or more facial muscle is a corrugator supercilii muscle, or a procerus muscle.

5 . The method of claim 1 , wherein the botulinum toxin in the composition is selected from the group consisting of the botulinum toxins types A, B, C 1 , D, E, F and G.

6 . The method of claim 5 , wherein the botulinum toxin in the composition is botulinum toxin A.

7 . The method of claim 1 , wherein the therapeutically effective amount is about 5-60 Unit equivalents of a botulinum toxin type A.

8 . The method of claim 7 , further comprising administering a second composition comprising an additional therapeutically effective amount of the botulinum toxin type A to the one or more facial muscle after about two to six months.

9 . The method of claim 1 , further comprising administering to the subject a therapeutically effective amount of an additional modality of treatment for depression.

10 . The method of claim 9 , wherein the additional modality of treatment comprises administration of an antidepressant, psychotherapy, or a physical treatment for depression.

11 . The method of claim 9 , wherein the additional modality of treatment comprises a selective serotonin reuptake inhibitor.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 2, 2024
From: MARYLAND MENTAL HEALTH INSTITUTE, LLC
To: HEALIS THERAPEUTICS, INC.
Reel/Frame 066178/0521 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2022
From: FINZI, ERIC
To: MARYLAND MENTAL HEALTH INSTITUTE, LLC
Reel/Frame 059124/0089 →